CompletedPhase 2

Study to Determine the Maximum Tolerated Dose and Safety of PEP005 Topical Gel

United States34 participantsStarted 2005-09

Plain-language summary

The purpose of this study is : * To determine the maximum tolerated dose (MTD) for PEP005 Topical Gel in patients with actinic keratoses. * To evaluate patients for clinical safety * To determine the systemic absorption of PEP005 Topical Gel

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Exclusion criteria

✕. within 5 cm of a scar
✕. within 5 cm of any actinic keratosis lesion not selected for treatment
✕. within 5 cm of an incompletely healed wound
✕. on the breast
✕. within 5 cm of an area previously treated with surgical excision

What they're measuring

Maximum Tolerated Dose (MTD)

Trial details

NCT IDNCT00239135

SponsorPeplin

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2005-12

View on ClinicalTrials.gov More Keratosis trials